Follow
Amy J. Petty, MD, PhD
Amy J. Petty, MD, PhD
Duke University Medical Center
Verified email at duke.edu
Title
Cited by
Cited by
Year
Tumor-associated macrophages: implications in cancer immunotherapy
AJ Petty, Y Yang
Immunotherapy 9 (3), 289-302, 2017
3202017
Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment
AJ Petty, A Li, X Wang, R Dai, B Heyman, D Hsu, X Huang, Y Yang
The Journal of clinical investigation 129 (12), 5151-5162, 2019
1952019
Tumor-associated macrophages in hematologic malignancies: new insights and targeted therapies
AJ Petty, Y Yang
Cells 8 (12), 1526, 2019
602019
Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function
AJ Petty, R Dai, R Lapalombella, RA Baiocchi, DM Benson, Z Li, X Huang, ...
JCI insight 6 (6), 2021
592021
The Wnt/β‐catenin/T‐cell factor 4 pathway up‐regulates high‐mobility group A1 expression in colon cancer
BM Bush, AT Brock, JA Deng, RA Nelson Jr, TF Sumter
Cell biochemistry and function 31 (3), 228-236, 2013
452013
Meta-analysis of number needed to treat for diagnosis of melanoma by clinical setting
AJ Petty, B Ackerson, R Garza, M Peterson, B Liu, C Green, M Pavlis
Journal of the American Academy of Dermatology 82 (5), 1158-1165, 2020
372020
Targeting tumor-associated macrophages in cancer immunotherapy
AJ Petty, DH Owen, Y Yang, X Huang
Cancers 13 (21), 5318, 2021
362021
Cutaneous lupus erythematosus: progress and challenges
AJ Petty, L Floyd, C Henderson, MW Nicholas
Current allergy and asthma reports 20, 1-10, 2020
302020
Skin viral infections: host antiviral innate immunity and viral immune evasion
V Lei, AJ Petty, AR Atwater, SA Wolfe, AS MacLeod
Frontiers in Immunology 11, 593901, 2020
272020
Chimeric antigen receptor cell therapy: overcoming obstacles to battle cancer
AJ Petty, B Heyman, Y Yang
Cancers 12 (4), 842, 2020
272020
Contact dermatitis associated with preservatives: Retrospective analysis of North American Contact Dermatitis Group data, 1994 through 2016
AR Atwater, AJ Petty, B Liu, CL Green, JI Silverberg, JG DeKoven, ...
Journal of the American Academy of Dermatology 84 (4), 965-976, 2021
232021
Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
AJ Petty, MJ Whitley, A Balaban, K Ellington, AL Marano
JAAD case reports 6 (8), 731-733, 2020
202020
High‐dose, high‐frequency ustekinumab therapy for patients with severe hidradenitis suppurativa
SW Jiang, JT Kwock, B Liu, AJ Petty, AT Zhao, CL Green, T Jaleel
British Journal of Dermatology 187 (3), 417-419, 2022
82022
Innate immunity in calcinosis cutis
SW Jiang, AJ Petty, MW Nicholas
Immuno 2 (3), 443-459, 2022
42022
Association between age at symptom onset and disease severity in older patients with hidradenitis suppurativa
SW Jiang, AJ Petty, JL Jacobs, C Robinson, SM Bhatia, JT Kwock, B Liu, ...
British Journal of Dermatology 188 (4), 555-576, 2023
32023
Analysis of clinical characteristics of drug-induced cutaneous lupus erythematosus in men
AJ Petty, AR Cardones, AL Marano
Journal of the American Academy of Dermatology 83 (5), 1455-1457, 2020
32020
Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea
AJ Petty, DA Emge, SK Blanchard, MA Selim, K Scoggins, B Liu, ...
Journal of the American Academy of Dermatology 89 (2), 390-392, 2023
22023
A Report on the Safety of Acitretin Use in Renal Failure Patients on Hemodialysis
PJ Shim, JL Quintos, K Faraz, IT Smith, AJ Petty, M Bottomley, ...
Clinical and Experimental Dermatology, llae093, 2024
2024
Immune Dysregulation and Current Targeted Biologics in Hidradenitis Suppurativa
R Chen, R Guo, AJ Petty, T Jaleel
Immuno 4 (1), 57-76, 2024
2024
43540 Association between protein gap and disease severity of hidradenitis suppurativa
J Jacobs, S Jiang, A Petty, J Kwock, T Jaleel
Journal of the American Academy of Dermatology 89 (3), AB4, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20